The Genesis of Animalia Biogenesis
Founded by veterinarian and lifelong pet parent Dr. Archith Sridhar, Animalia Biogenesis was born out of a desire to offer better solutions for chronic and progressive conditions in pets. Dr. Sridhar frequently witnessed the limitations of traditional treatments for conditions like arthritis, kidney failure, and chronic wounds.
“Long-term medications provide temporary relief but fail to address the root cause of these ailments,” says Dr. Sridhar. This realization, coupled with his commitment to improving pet care, led to the development of Animalia Biogenesis.
The Promise of Regenerative Medicine
The cornerstone of Animalia Biogenesis is its flagship offering, PetStem Therapy. This groundbreaking treatment combines stem cells and Platelet-Rich Plasma (PRP) to accelerate healing, reduce inflammation, and repair damaged tissues. Unlike conventional treatments requiring ongoing medication or surgeries, PetStem Therapy offers a one-time, cost-effective solution.
“Using the pet’s own cells minimizes the risk of adverse reactions while ensuring a natural, long-lasting recovery,” explains Dr. Sridhar.
Overcoming Challenges and Building Trust
Introducing regenerative medicine to the Indian veterinary landscape was no easy feat. Animalia Biogenesis faced significant challenges, including skepticism among veterinarians and lack of awareness among pet owners. Dr. Sridhar and his team responded with educational initiatives, seminars, and social media campaigns to build confidence in these advanced therapies.
Additionally, developing in-house protocols and infrastructure allowed the organization to maintain high standards while reducing costs, making treatments accessible to a broader audience.
Committed to Safety and Excellence
Animalia Biogenesis ensures stringent quality control through in-house treatment development. Protocols align with international standards, and a highly trained team collaborates with veterinarians to deliver precision-based therapies. Continuous refinement of processes based on outcomes guarantees optimal results for pets.
Expanding Access Through Collaboration
The organization partners with NGOs and rescue centers to subsidize treatments for stray animals, ensuring even the most vulnerable pets receive care. Educational campaigns further promote awareness of the benefits of regenerative therapies, highlighting their potential to treat conditions early and effectively.
Reimagining Veterinary Care in India
Animalia Biogenesis envisions a future where regenerative medicine becomes the gold standard for treating chronic and degenerative conditions in pets. Beyond arthritis and kidney failure, the organization plans to expand its focus to autoimmune disorders, atopic dermatitis, cancer, and more.
“With early intervention, we can halt or reverse disease progression, offering pets healthier and happier lives,” Dr. Sridhar emphasizes.
A Mission of Compassion and Innovation
Animalia Biogenesis is committed to delivering cutting-edge, accessible solutions that enhance pets’ quality of life and provide peace of mind to their families. By blending science, compassion, and education, the organization is redefining pet care in India.
For more information, visit www.animaliabiogenesis.com, follow Animalia Biogenesis on Instagram (@animaliabiogenesis) and Facebook, or reach out via email at archith@animaliabiogenesis.com or phone at +91 99406 62347
